OpenURL Connection Search

Select item for more details and to access through your institution.

Animal models for metabolic, neuromuscular and ophthalmological rare diseases.
Published in:
2013
By:
- Vaquer, Guillaume;
- Rivière, Frida;
- Mavris, Maria;
- Bignami, Fabrizia;
- Llinares-Garcia, Jordi;
- Westermark, Kerstin;
- Sepodes, Bruno
Publication type:
journal article
Animal models for metabolic, neuromuscular and ophthalmological rare diseases.
Published in:
Nature Reviews Drug Discovery, 2013, v. 12, n. 4, p. 287, doi. 10.1038/nrd3831
By:
- Vaquer, Guillaume;
- Dannerstedt, Frida Rivière;
- Mavris, Maria;
- Bignami, Fabrizia;
- Llinares-Garcia, Jordi;
- Westermark, Kerstin;
- Sepodes, Bruno
Publication type:
Article
European regulation on orphan medicinal products: 10 years of experience and future perspectives.
Published in:
2011
By:
- Committee for Orphan Medicinal Products and the European Medicines;
- Westermark, Kerstin;
- Holm, Birthe Byskov;
- Söderholm, Mirjam;
- Llinares-Garcia, Jordi;
- Rivière, Frida;
- Aarum, Stiina;
- Butlen-Ducuing, Florence;
- Tsigkos, Stelios;
- Wilk-Kachlicka, Agnieszka;
- N'Diamoi, Cinzia;
- Borvendég, János;
- Lyons, David;
- Sepodes, Bruno;
- Bloechl-Daum, Brigitte;
- Lhoir, André;
- Todorova, Mariana;
- Kkolos, Ioannis;
- Kubáčková, Kateřina;
- Bosch-Traberg, Heidrun
Publication type:
review
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.
Published in:
2021
By:
- Eichler, Hans-Georg;
- Adams, Roisin;
- Andreassen, Einar;
- Arlett, Peter;
- van de Casteele, Marc;
- Chapman, Suzannah J.;
- Goettsch, Wim G.;
- Martinsson, Jonathan Lind;
- Llinares-Garcia, Jordi;
- Nachtnebel, Anna;
- Pean, Elias;
- Rasi, Guido;
- Reksten, Tove Ragna;
- Timmers, Lonneke;
- Vreman, Rick A.;
- van de Vijver, Inneke;
- Wenzl, Martin
Publication type:
journal article
Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020.
Published in:
Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 1, p. 69, doi. 10.1002/cpt.2554
By:
- Bakker, Elisabeth;
- Hendrikse, Natalie M.;
- Ehmann, Falk;
- van der Meer, Daniëlla S.;
- Llinares Garcia, Jordi;
- Vetter, Thorsten;
- Starokozhko, Viktoriia;
- Mol, Peter G.M.
Publication type:
Article

Found: 5

Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

European regulation on orphan medicinal products: 10 years of experience and future perspectives.

Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.

Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020.